Cellosaurus logo
expasy logo

Cellosaurus NYH/TPT (CVCL_0B28)

[Text][XML][JSON]
Cell line name NYH/TPT
Accession CVCL_0B28
Resource Identification Initiative To cite this cell line use: NYH/TPT (RRID:CVCL_0B28)
Comments Selected for resistance to: ChEBI; CHEBI_63632; Topotecan.
Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
Disease Lung small cell carcinoma (NCIt: C4917)
Small cell lung cancer (ORDO: Orphanet_70573)
Species of origin Homo sapiens (Human) (NCBI Taxonomy: 9606)
Hierarchy Parent: CVCL_8207 (GLC-2)
Sex of cell Male
Age at sampling 41Y
Category Cancer cell line
Publications

PubMed=7640225; DOI=10.1038/bjc.1995.345; PMCID=PMC2034011
Morten Sorensen, Maxwell Sehested, Peter Buhl Jensen;
Characterisation of a human small-cell lung cancer cell line resistant to the DNA topoisomerase I-directed drug topotecan.
Br. J. Cancer 72:399-404(1995)

PubMed=9062409; DOI=10.1038/bjc.1997.154; PMCID=PMC2063407
Peter Buhl Jensen, Bente Holm, Morten Sorensen, Ib Jarle Christensen, Maxwell Sehested;
In vitro cross-resistance and collateral sensitivity in seven resistant small-cell lung cancer cell lines: preclinical identification of suitable drug partners to taxotere, taxol, topotecan and gemcitabin.
Br. J. Cancer 75:869-877(1997)

Cross-references
Encyclopedic resources Wikidata; Q54931219
Entry history
Entry creation10-Apr-2015
Last entry update19-Dec-2024
Version number9